Expression of p53 in Saos-2 osteosarcoma cells induces apoptosis which can be inhibited by Bcl-2 or the adenovirus E1B-55 kDa protein

Cell Growth and Differentiation

Volumn 7, Issue 12, 1996, Pages 1643-1650

  Marcellus, R C ^a   Teodoro, J G ^a   Charbonneau, R ^a   Shore, G C ^a   Branton, P E ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53; VIRUS PROTEIN;

ADENOVIRUS 5; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ETIOLOGY; GENE TRANSFER; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPRESSOR GENE;

ADENOVIRUS E1B PROTEINS; APOPTOSIS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROSCOPY, ELECTRON; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5;

EID: 0029847416     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Levine, A. J., Chang, A., Dittmer, D., Notterman, D. A., Silver, A., Thorn, K., Welsh, D., and Wu, M. The p53 tumor suppressor gene. J. Lab. Clin. Med, 123: 817-823, 1994.
2. Linzer, D. I., and Levine, A. J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell, 17: 43-52, 1979.
3. Sarnow, P., Ho, Y. S., Williams, J., and Levine, A. J. Adenovirus E1b 58Kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54Kd cellular protein in transformed cells. Cell, 28: 387-394, 1982.
4. Yew, P. R., Kao, C. C., and Berk, A. J. Dissection of functional domains in the adenovirus 2 early 1B 55K polypeptide by suppressor-linker insertional mutagenesis. Virology, 179: 795-805, 1990.
5. Scheffner, M., Huibregtse, J. M., Vierstra, R. D., and Howley, P. M. The HPV-16 E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell, 75: 495-505, 1993.
6. Chang, F., Syrjanen, S., Kurvinen, K., and Syrjanen, K. The p53-tumor suppressor gene as a common cellular target in human carcinogenesis. Am. J. Gastroenterol., 88: 174-186, 1993.
7. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. J., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (Lond.), 356: 215-221, 1992.
8. Finlay, C. A., Hinds, P. W., and Levine, A. J. The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57: 1083-1093, 1989.
9. Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., Vogelstein, B., and Friend, S. H. p53 functions as a cell cycle protein in osteosarcoma. Mol. Cell. Biol., 10: 5772-5781, 1990.
10. Ginsberg, D., Michael, M. D., Ginsberg, D., and Oren, M. Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Mol. Cell. Biol., 11: 582-585, 1991.
11. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell, 71: 587-597, 1992.
12. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemia cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.
13. Ginsberg, D., Mechta, F., Yaniv, M., and Oren, M. Wild-type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA, 88: 9979-9983, 1991.
14. Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., and Prives, C. Wild-type p53 activates transcription in vitro. Nature (Lond.), 358: 83-86, 1992.
15. Subler, M. A., Martin, D. W., and Deb, S. Inhibition of viral and cellular promoters by wild-type p53. J. Virol., 66: 4757-4762, 1992.
16. Zambetti, G. P., Bargonetti, J., Walker, K., Prives, C., and Levine, A. J. (1992) Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev., 6: 1143-1152, 1992.
17. Fields, S., and Jang, S. K. Presence of a potent transcription activating sequence in the p53 protein. Science (Washington DC), 249: 1046- 1049, 1990.
18. Santhanam, U., Ray, A., and Sehgal, P. B. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA, 88: 7605-7609, 1991.
19. Chin, K. V., Ueda, K., Pastan, I., and Gottesman, M. M. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science (Washington DC), 255: 459-462, 1992.
20. Kley, N., Chung, R. Y., Fay, S., Loeffler, J. P., and Seizinger, B. R. Repression of the basal c-fos promoter by wild-type p53. Nucleic Acids Res., 20: 4083-4087, 1992.
21. Debbas, M., and White, E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev., 7: 546-554, 1993.
22. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
23. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995.
24. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
25. Kao, C. C., Yew, P. R., and Berk, A. J. Domains required for in vitro association between cellular p53 and the adenovirus 2 E1B 55K protein. Virology, 179: 806-814, 1990.
26. Yew, P. R., and Berk, A. J. Inhibition of p53 transactivation required for transformation by adenovirus early region 1B protein. Nature (Lond.), 357: 82-85, 1992.
27. Yew, P. R., Liu, X., and Berk, A. J. Adenovirus E1A oncogene tethers a transcriptional repression domain to p53. Genes Dev., 8: 190-202, 1994.
28. Teodoro, J. G., Shore, G. C., and Branton, P. E. Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene, 11: 467-474, 1995.
29. Teodoro, J. G., Halliday, T., Whalen, S. G., Takayesu, D., Graham, F. L., and Branton, P. E. Phosphorylation at the carboxy terminus of the 55-kilodalton adenovirus type 5 E1B protein regulates transforming activity. J. Virol., 58: 776-786, 1994.
30. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53- dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
31. Masuda, H., Miller, C., Koeffler, H. P., Battifora, H., and Cline, M. J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl. Acad. Sci. USA, 84: 7716-7719, 1987.
32. Chen, P. L., Chen, Y. M., Bookstein, R., and Lee, W. H. Genetic mechanisms of tumor suppression by the human p53 gene. Science (Washington DC), 250: 1576-1580, 1990.
33. Wang, J., Bucana, C. D., Roth, J. A., and Zhang, W. W. Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53. Cancer Gene Therapy, 2: 9-17, 1995.
34. Chiou, S. K., Rao, L., and White, E. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol., 14: 2556-2563, 1994.
35. Zhuang, S. M., Shvarts, A., Jochemsen, A. G., van Oorschot, A. A., van der Eb, A. J., and Noteborn, M. H. Differential sensitivity to Ad5 E1B-21 kD and Bcl-2 proteins of apoptin-induced versus p53-induced apoptosis. Carcinogenesis (Lond.), 16: 2939-2944, 1995.
36. Kerr, J. F., Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
37. Searle, J., Lawson, T. A., Abbott, P. J., Harmon, B., and Kerr, J. F. An electron microscopic study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J. Pathol., 116: 129-138, 1975.
38. Subramanian, T., Tarodi, B., and Chinnadurai, G. p53-independent apoptotic and necrotic cell deaths induced by adenovirus infection: suppression by E1B 19K and Bcl-2 proteins. Cell Growth & Differ., 6: 131-137, 1995.
39. Marcellus, R. C., Teodoro, J. G., Wu, T., Brough, D. E., Ketner, G., Shore, G. C., and Branton, P. E. Adenovirus 5 early region 4 is responsible for E1A-induced p53-independent apoptosis J. Viral., 70: 6207-6215, 1996.
40. White, E., Sabbatini, P., Debbas, M., Wold, W. S. M., Kusher, D., and Gooding, L. R. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α. Mol. Cell. Biol., 12: 2570-2580, 1992.
41. Rao, L., Debbas, M., Sabbatini, P., Hockenbery, D., Korsmeyer, S., and White, E. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19 kDa and bcl-2 proteins. Proc. Natl. Acad. Sci. USA, 89: 7742-7746, 1992.
42. Boyd, J. M, Malstrom, S., Subramanian, T., Venkatesh, L. K., Schaeper, U., Elangovan, B., D'Sa-Eipper, C., and Chinnadurai, G. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell, 79: 341-351, 1994.
43. Nguyen, M., Branton, P. E., Walton, P. A., Korsmeyer, S. J., and Shore, G. C. Role of the membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. J. Biol. Chem., 269: 16521-16524, 1994.
44. Buckbinder, L., Talbott, R., Seizinger, B. R., and Kley, N. Gene regulation by temperature sensitive p53 mutants: identification of p53 response. Proc. Natl. Acad. Sci. USA, 91: 10640-10644, 1994.
45. Radinsky, R., Fidler, I. J., Price, J. E., Esumi, N., Tsan, R., Petty, C. M., Bucana, C. D., and Bar-Eli, M. Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene, 9: 1877-1883, 1994.
46. Yamato, K., Yamamoto, M., Hirano, Y., and Tsuchida, N. A human temperature-sensitive p53 mutant p53Val-138: modulation of the cell cycle, viability and expression of p53-responsive genes. Oncogene, 11: 1-6, 1995.
47. Maheswaran, S., Englert, C., Bennett, P., Heinrich, G., and Haber, D. A. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev., 9: 2143-2156, 1995.
48. Zhuang, S. M., Shvarts, A., Jochemsen, A. G., van Oorschot, A. A. A. M., van der Eb, A. J., and Noteborn, M. H. M. Differential sensitivity to Ad5 E1B-21 kD and Bcl-2 proteins of apoptin-induced versus p53-induced apoptosis. Carcinogenesis (Lond.), 16: 2939-2944, 1995.
49. Wang, J., Bucana, C. D., Roth, J. A., and Zhang, W. W. Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53. Cancer Gene Ther., 2: 9-17, 1995.
50. Morgenbesser, S. D., Williams, B. O., Jacks, T., and DePinho, R. A. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature (Lond.), 371: 72-74, 1994.
51. Nevins, J. R. Transcriptional activation by viral regulatory proteins. Trends Biochem. Sci., 16: 35-439, 1991.
52. Oltvai, Z. N., and Korsmeyer, S. J. Checkpoints of duelling dimers foil death wishes. Cell, 79: 189-192, 1994.
53. Ezoe, H., Lai Fatt, R. B., and Mak, S. Degradation of intracellular DNA in KB cells infected with cyt mutants of human adenovirus type 12. J. Virol., 40: 20-27, 1981.
54. Pilder, S., Logan, J., and Shenk, T. Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA. J. Virol., 52: 664-671, 1984.
55. Subramanian, T., Kuppuswamy, M., Gysbers, J., Mak, S., and Chinnadurai, G. 19 kDa tumor antigen coded by early region E1b of adenovirus 2 is required for efficient synthesis and for protection of viral DNA. J. Biol. Chem., 259: 11777-11783, 1984.
56. White, E., Cipriani, R., Sabbatini, P., and Denton, A. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol., 65: 2968-2978, 1991.
57. Rowe, D. T., Graham, F. L., and Branton, P. E. Intracellular localization of adenovirus type 5 tumor antigens in productively infected cells. Virology, 129: 456-468, 1983.
58. Bacchetti, S., and Graham, F. L. Inhibition of cell proliferation by an adenovirus vector expressing the human wild type p53 protein. Int. J. Oncol., 78: 781-788, 1993.
59. Graham, F. L., and van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52: 456-467, 1972.
60. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 343: 334-336, 1990.
61. Banks, L., Matlashewski, G., and Crawford, L. Isolation of human- p53-specific monoclonal antibodies and their use in the studies of p53 expression. Eur. J. Biochem., 159: 529-534, 1986.
62. el-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., and Vogelstein, B. Human genomic DNA sequences define a consensus binding site for p53. Nat. Genet. 1: 45-49, 1992.
63. Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P. Regulation of the specific DNA function of p53. Cell, 71: 875-86, 1992.